Biological Psychiatry: Volume 89 (Issue 1 to Issue 12)
Biological Psychiatry, founded in 1969, is an official journal of the Society of Biological Psychiatry and the first in the Biological Psychiatry family of journals. Companion titles include Biological Psychiatry: Cognitive Neuroscience and Neuroimaging and Biological Psychiatry: Global Open Science. The Society’s purpose is to promote excellence in scientific research and education in fields that investigate the nature, causes, mechanisms and treatments of disorders of thought, emotion, and behavior. In accord with this mission, this peer-reviewed, rapid-publication, international journal publishes novel results of original basic, translational, and clinical mechanistic research that advances our understanding of psychiatric disorders and their treatment. Reviews and commentaries that focus on topics of current research and interest are also encouraged.
Biological Psychiatry is one of the most selective and highly cited journals in the field of psychiatric neuroscience. The 2020 Impact Factor score for Biological Psychiatry is 12.810. In the 2021 Journal Citation Reports published by Clarivate Analytics, it is ranked 13th out of 263 Psychiatry titles and 14th out of 277 Neurosciences titles, by Impact Factor. By total citations, Biological Psychiatry is ranked 1st in Psychiatry. It is also the 5th ranked journal in Psychiatry according to Google Scholar (July 2022).
Biological Psychiatry‘s acceptance rate is less than 10%. The average time from submission to first decision is less than 20 days, with an editorial rejection (reject without peer review) decision issued within 5 days. Accepted articles are published online, prior to copyediting, within one week of final acceptance, with the corrected proof later replacing that version. Articles are generally published in print 6-8 months after acceptance.
More information about the journal and the Society of Biological Psychiatry is available through links on this page. In addition to offering the finest reports in psychiatric neuroscience today, we hope to bring the journal’s information to you in the most user-friendly and easily accessible manner. Therefore, your feedback is welcome at [email protected].
No responsibility is assumed by the Publisher or by the Society of Biological Psychiatry for any injury and/or damages to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. No suggested test or procedure should be carried out unless, in the reader’s judgment, its risk is justified. Because of rapid advances in the medical sciences, we recommend the independent verification of diagnoses and drug dosages. Discussions, views, and recommendations as to medical procedures, choice of drugs, and drug dosages are the responsibility of the authors.
Disentangling Psychiatric Polygenicity
Volume 89, Issue 1, Pages A1-A10, 1-90 (1 January 2021)
Adolescent Brain Development and Psychopathology
Volume 89, Issue 2, Pages A1-A10, 91-204 (15 January 2021)
Transdiagnostic Perspectives on Psychosis Risk
Volume 89, Issue 3, Pages A1-A12, e1-e10, 205-320 (1 February 2021)
Structural and Functional Impact of Cocaine
Volume 89, Issue 4, Pages A1-A10, e11-e20, 321-414 (15 February 2021)
Novel Neurodevelopmental Disturbances and Autism Risk
Volume 89, Issue 5, Pages A1-A10, e21-e30, 415-532 (1 March 2021)
Early Developmental Antecedents of Mood Disorders
Volume 89, Issue 6, Pages A1-A12, e31-e36, 533-636 (15 March 2021)
Pediatric Anxiety Disorders
Volume 89, Issue 7, Pages A1-A10, 637-734 (1 April 2021)
Late-Life Depression and Dementia
Volume 89, Issue 8, Pages A1-A14, e37-e44, 735-836 (15 April 2021)
2021 Annual Scientific Convention and Meeting
Volume 89, Issue 9, Supplement, Pages A1-A12, S1-S388 (1 May 2021)
Stress Vulnerability and Moderators of Stress Response
Volume 89, Issue 9, Pages A1-A10, e45-e50, 837-938 (1 May 2021)
Addiction: Reward Learning and Neuroplasticity
Volume 89, Issue 10, Pages A1-A12, e51-e57, 939-1022 (15 May 2021)
Glutamate-Dopamine Interactions in Antidepressant Efficacy
Volume 89, Issue 11, Pages A1-A12, e59-e62, 1023-1106 (1 June 2021)
Mechanisms of Stress and Fear
Volume 89, Issue 12, Pages A1-A10, e63-e74, 1107-1196 (15 June 2021)
Reviews
There are no reviews yet.